Healthtech Investors & VC Firms in India
197 firms in this list, with a median first check of $500K. 50 of them lead rounds. Generated from verified public data and updated continuously.
Unilever Ventures
LondonSeed–Late Stage$540K – $10.8M
15 people
SEAF
WashingtonGrowth$3M – $7M
27 people
Aavishkaar Venture Management Services Private Limited
MumbaiSeed–Growth$5M – $25M
23 people
Evolvence India Fund
MumbaiSeed–Late Stage
20 people
iSeed
BangalorePre-Seed–Series A$250K
1 person
SucSEED Indovation
HyderabadPre-Seed–Growth$4K – $1.1M
11 people
Avataar Venture Partners
BangaloreSeries A–Late Stage$10M – $30M
22 people
VenturEast
BangaloreSeed–Late Stage
12 people
Yunus Social Business Colombia
BerlinSeed–Growth
32 people
The Chennai Angels
ChennaiPre-Seed–Series A$148K – $1.5M
20 people
Elevar Equity
BengaluruPre-Seed–Late Stage$1M – $10M
18 people
SenseAI Ventures
IndiaPre-Seed–Series A
19 people
Blue Ashva Capital
Series A$1M – $5M
23 people
Pentathlon Ventures
IndiaPre-Seed–Series A
17 people
Together Fund
BangaloreSeed–Series A$1M – $10M
13 people
Btomorrow Ventures
LondonSeed–Growth
21 people
CapitalOven
KolkataPre-Seed–Series A$500K – $10M
5 people
Z21 Ventures
San Francisco Bay AreaPre-Seed–Series A$500K – $1M
11 people
Exfinity Ventures
BengaluruPre-Seed–Series A$500K – $3.5M
16 people
Mars Shot Ventures
Pre-Seed–Series A
9 people
Bertelsmann India Investments
NoidaSeries A–Late Stage$5M – $15M
23 people
Incubate Fund
TokyoPre-Seed–Seed
12 people
Smash Capital
New YorkSeries C–Late Stage
22 people
Tanglin Venture Partners
SingaporeSeed–Series B$8M
17 people
Related lists
Investors & VC Firms in United States (5050)Crypto & Web3 Investors & VC Firms (4688)Investors & VC Firms in Global (4044)SaaS Investors & VC Firms (3602)AI & Machine Learning Investors & VC Firms (3577)Fintech Investors & VC Firms (3506)Healthtech Investors & VC Firms (3208)Enterprise Software Investors & VC Firms (3098)Investors & VC Firms in Europe (2833)Healthtech Seed Investors & VC Firms (2488)
Data sourced from public filings and firms' own websites — see our methodology.

















































































